Molecular Targets of Tannic Acid in Alzheimer's Disease

被引:37
|
作者
Braidy, Nady [1 ,2 ]
Jugder, Bat-Erdene [2 ]
Poljak, Anne [1 ,3 ]
Jayasena, Tharusha [1 ]
Nabavi, Seyed Mohammad [4 ]
Sachdev, Perminder [1 ,5 ]
Grant, Ross [3 ,6 ,7 ]
机构
[1] Univ New South Wales, Sch Psychiat, Ctr Hlth Brain Ageing, Sydney, NSW, Australia
[2] Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia
[3] Univ New South Wales, Sch Med Sci, Sydney, NSW, Australia
[4] Baqiyatallah Univ Med Sci, Appl Biotechnol Res Ctr, Tehran, Iran
[5] Prince Wales Hosp, Neuropsychiat Inst, Sydney, NSW, Australia
[6] Sydney Adventist Hosp, Australasian Res Inst, Sydney, NSW, Australia
[7] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia
基金
澳大利亚国家健康与医学研究理事会; 英国医学研究理事会;
关键词
Tannic acid; Alzheimer's disease; A beta pathology; tau; beta-secretase; neurons; AMYLOID PRECURSOR PROTEIN; MEMAPSIN-2; BETA-SECRETASE; DENDRITIC SPINE PATHOLOGY; GALLIC ACID; TAU-PROTEIN; COGNITIVE IMPAIRMENT; CEREBRAL-HEMORRHAGE; ACUTE TOXICITY; CELL BIOLOGY; HUMAN HEALTH;
D O I
10.2174/1567205014666170206163158
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Tannic acid (TA) is a naturally occurring plant-derived polyphenol found in several herbaceous and woody plants, including legumes, sorghum, beans, bananas, persimmons, rasberries, wines and a broad selection of teas. Clinically, TA has strong antioxidant/free radical scavenging, antiinflammatory, anti-viral/bacterial, and anti-carcinogenic properties. While the aetiology of Alzheimer's disease (AD) remains unclear, this complex multifactorial neurodegenerative disorder remains the most common form of dementia, and is a growing public health concern worldwide. The neuroprotective effects of TA against AD have been shown in several in vitro and in vivo models of AD. Apart from its potent antioxidant and anti-inflammatory roles, evidence suggests that TA is also a natural inhibitor of beta-secretase (BACE1) activity and protein expression. BACE1 is the primary enzyme responsible for the production and deposition of A beta peptide. TA also destabilises neurotoxic amyloid beta (A beta) fibrils in vitro. Apart from its effects on the A beta cascade, TA can also inhibit the in vitro aggregation of tau peptide, a core component of intracellular neurofibrillary tangles (NFTs). This review summarizes the relevance of TA and TA-related vegetable extracts (tannins) in the pathogenesis of AD and its enzymatic targets. It also highlights the significance of TA as an important lead compound against AD.
引用
收藏
页码:861 / 869
页数:9
相关论文
共 50 条
  • [1] Molecular Targets in Alzheimer’s Disease
    Geir Bjørklund
    Jan Aaseth
    Maryam Dadar
    Salvatore Chirumbolo
    [J]. Molecular Neurobiology, 2019, 56 : 7032 - 7044
  • [2] Molecular Targets in Alzheimer's Disease
    Bjorklund, Geir
    Aaseth, Jan
    Dadar, Maryam
    Chirumbolo, Salvatore
    [J]. MOLECULAR NEUROBIOLOGY, 2019, 56 (10) : 7032 - 7044
  • [3] Molecular and Therapeutic Targets of Genistein in Alzheimer’s Disease
    Kasi Pandima Devi
    Balakrishnan Shanmuganathan
    Azadeh Manayi
    Seyed Fazel Nabavi
    Seyed Mohammad Nabavi
    [J]. Molecular Neurobiology, 2017, 54 : 7028 - 7041
  • [4] Alzheimer's disease: Molecular concepts and therapeutic targets
    Fassbender K.
    Masters C.
    Beyreuther K.
    [J]. Naturwissenschaften, 2001, 88 (6) : 261 - 267
  • [5] Alzheimer's disease: molecular concepts and therapeutic targets
    Fassbender, K
    Masters, C
    Beyreuther, K
    [J]. NATURWISSENSCHAFTEN, 2001, 88 (06) : 261 - 267
  • [6] Molecular and Therapeutic Targets of Genistein in Alzheimer's Disease
    Devi, Kasi Pandima
    Shanmuganathan, Balakrishnan
    Manayi, Azadeh
    Nabavi, Seyed Fazel
    Nabavi, Seyed Mohammad
    [J]. MOLECULAR NEUROBIOLOGY, 2017, 54 (09) : 7028 - 7041
  • [7] Molecular drug targets and therapies for Alzheimer's disease
    Singh, Dev Bukhsh
    Gupta, Manish Kumar
    Kesharwani, Rajesh Kumar
    Sagar, Mamta
    Dwivedi, Seema
    Misra, Krishna
    [J]. TRANSLATIONAL NEUROSCIENCE, 2014, 5 (03) : 203 - 217
  • [8] Emerging molecular targets - A key to Alzheimer's disease?
    Gurwitz, D
    [J]. DRUG DISCOVERY TODAY, 1998, 3 (03) : 144 - 144
  • [9] Emerging Therapeutic Targets in Molecular Neuropharmacology for Alzheimer's Disease
    Bano, Sarika
    Raza, Muhammad Asim
    Ghosh, Shampa
    Pandit, Nayaab S.
    Srivastava, Saumya
    Azam, Mohammad
    Dey, Sanjay Kumar
    Han, Sung Soo
    Sinha, Jitendra Kumar
    Ruwali, Munindra
    [J]. JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2023, 37 (11): : 5769 - 5784
  • [10] Molecular network of microRNA targets in Alzheimer's disease brains
    Satoh, Jun-ichi
    [J]. EXPERIMENTAL NEUROLOGY, 2012, 235 (02) : 436 - 446